Dallas C E, Chen X M, Muralidhara S, Varkonyi P, Tackett R L, Bruckner J V
Department of Pharmacology and Toxicology, College of Pharmacy, University of Georgia, Athens 30602-2356.
Environ Res. 1994 Oct;67(1):54-67. doi: 10.1006/enrs.1994.1064.
Tissue disposition of perchloroethylene (PCE) was determined experimentally in two mammalian species of markedly different size in order to derive input parameters for the development of a physiologically based pharmacokinetic (PBPK) model, which could forecast the disposition of PCE in each species. Male Sprague-Dawley rats and male beagle dogs received a single bolus of 10 mg PCE/kg body wt in polyethylene glycol 400 by gavage. Serial samples of brain, liver, kidney, lung, heart, skeletal muscle, perirenal fat, and blood were taken for up to 72 hr following PCE administration. Blood and tissue PCE concentrations were analyzed using a gas chromatography headspace technique. Dogs exhibited considerably longer tissue and blood half-lives than did rats. The dogs also exhibited larger area under tissue concentration versus time curves for all tissues except the liver. Whole body clearance of PCE in the rat was greater than that in the dog. Model simulations indicated this could be attributed to more rapid and extensive PCE exhalation and metabolism by the rat. The in vivo blood:air partition coefficient determined for rats was similar to an in vitro value previously reported. In vivo tissue: blood partition coefficients, however, were 1.4 to 2.8 times greater than published in vitro values. The PCE in vivo blood:air partition coefficient for the dog was twice that of the rat, but tissue:blood partition coefficients were 1.5 to 3.0 times greater in the rat than in the dog. These results demonstrated the existence of significant differences in partition coefficients in two species commonly used in toxicity testing. The PBPK model was shown to have utility in predicting the impact of metabolism and exhalation on pharmacokinetics of PCE in different species of widely differing size.
为了获得用于构建基于生理的药代动力学(PBPK)模型的输入参数,以便预测全氯乙烯(PCE)在每种动物体内的处置情况,对两种体型差异显著的哺乳动物进行了PCE组织处置的实验研究。雄性斯普拉格 - 道利大鼠和雄性比格犬通过灌胃给予10 mg PCE/kg体重的聚乙二醇400单次大剂量药物。在给予PCE后的72小时内,连续采集脑、肝、肾、肺、心脏、骨骼肌、肾周脂肪和血液样本。使用气相色谱顶空技术分析血液和组织中的PCE浓度。与大鼠相比,犬的组织和血液半衰期长得多。除肝脏外,犬在所有组织中的组织浓度 - 时间曲线下面积也更大。大鼠体内PCE的全身清除率高于犬。模型模拟表明,这可能归因于大鼠对PCE的呼出和代谢更快且更广泛。测定的大鼠体内血 - 气分配系数与先前报道的体外值相似。然而,体内组织 - 血分配系数比已发表的体外值大1.4至2.8倍。犬体内PCE的血 - 气分配系数是大鼠的两倍,但大鼠的组织 - 血分配系数比犬大1.5至3.0倍。这些结果表明,在毒性测试中常用的两种动物中,分配系数存在显著差异。结果表明,PBPK模型可用于预测代谢和呼出对不同体型的不同物种中PCE药代动力学的影响。